Journal of toxicologyOct 17, 2026

Safety Concerns and Risks of Modified mRNA Vaccine Technology Based on COVID-19 Experience

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Oct 18, 2026

Abstract

Five years post-rollout, accumulating evidence has highlighted safety signals associated with modified mRNA vaccines.

Certain toxicological risks related to modified mRNA vaccines may not have been fully addressed due to the rapid deployment timeline.
Safety signals identified include concerns about biodistribution, off-target effects, and persistent adverse events.
Independent analyses of Phase III trial data and pharmacovigilance reports raise questions regarding the benefit-risk balance.
Potential long-term biological effects of modified RNA vaccine technology require closer scrutiny.
The review identifies areas of uncertainty that could inform future development and regulatory evaluation.

Simplified

The rapid deployment in early 2021 of modified mRNA (modRNA) as a vaccine platform for the COVID-19 pandemic sparked a wave of optimism for its potential as a preventive medicine. However, this compacted timeframe may not have fully addressed certain toxicological risks associated with this new technology, which would typically require more extensive preclinical testing. Five years postrollout, an accumulating body of postauthorisation evidence has highlighted safety signals that require closer scrutiny, such as those concerning biodistribution, off-target effects and persistent adverse events. Independent analyses of Phase III trial data and pharmacovigilance reports have raised questions regarding benefit-risk balance and potential long-term biological effects. This narrative review examines the evolution of the toxicological understanding of modified RNA as a vaccine technology from platform design through long-term observational data, identifying areas of uncertainty and vulnerability that may inform future development and regulatory evaluation. The review emphasises that fast-tracked decision-making under exceptional uncertainty requires explicit safeguards to prevent premature certainty and to support learning from emerging evidence over time.

Full Text

Full text is available at the source.

View Full Text ↗

Safety Concerns and Risks of Modified mRNA Vaccine Technology Based on COVID-19 Experience

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief